MERRIMACK PHARMACEUTICALS INC Shareholders' Equity
MERRIMACK PHARMACEUTICALS INC had Shareholders' Equity of $221.65 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-05-15
- 2024-03-31: Stockholders' Equity Attributable to Parent $221.65M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $18.75M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $18.81M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $19.04M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-03-31 | $221.65M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $18.75M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $18.81M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $19.04M 10-Q · filed 2023-11-02 |
| 2023-03-31 | $19.17M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $19.25M 10-Q · filed 2024-05-15 |
| 2022-09-30 | $13.19M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $13.61M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $14.07M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $14.19M 10-K · filed 2024-03-07 |
| 2021-09-30 | $14.62M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $15.09M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $15.76M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $16.01M 10-K · filed 2023-03-09 |
| 2020-09-30 | $16.74M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $17.35M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $18.05M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $17.31M 10-K · filed 2022-03-09 |
| 2019-09-30 | $20.10M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $40.04M 10-Q · filed 2020-11-04 |
| 2019-03-31 | $48.96M 10-Q · filed 2020-11-04 |
| 2018-12-31 | $58.82M 10-K · filed 2021-03-10 |
| 2018-09-30 | $67.04M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $62.28M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $79.25M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $96.28M 10-K · filed 2020-03-12 |
| 2017-09-30 | $111.63M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $106.51M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$275.74M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$251.12M 10-K · filed 2019-03-06 |
| 2016-09-30 | -$226.78M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$201.40M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$217.20M 10-Q · filed 2016-05-02 |
| 2015-12-31 | -$183.93M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$141.15M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$143.34M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$129.22M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$102.14M 10-K · filed 2018-03-12 |
| 2014-09-30 | -$99.71M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$77.11M 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$65.96M 10-Q · filed 2014-05-06 |
| 2013-12-31 | -$43.47M 8-K · filed 2017-12-15 |
| 2013-09-30 | -$16.26M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$58.10M 10-Q · filed 2013-08-08 |
| 2013-03-31 | -$32.07M 10-Q · filed 2013-05-13 |
| 2012-12-31 | -$6.52M 10-K · filed 2016-02-26 |
| 2012-09-30 | $12.80M 10-Q · filed 2012-11-14 |
| 2011-12-31 | -$290.49M 10-K · filed 2015-02-27 |
| 2010-12-31 | -$219.96M 10-K · filed 2014-03-04 |
| 2009-12-31 | -$190.76M 10-K · filed 2013-03-20 |